Abstract:Background: Influenza-associated pulmonary aspergillosis (IAPA) is a severe fungal superinfection in critically ill influenza patients that is of incompletely understood pathogenesis. Despite the use of contemporary therapies with antifungal and antivirals, mortality rates remain unacceptably high. We aimed to unravel the IAPA immunopathogenesis as a means to develop adjunctive immunomodulatory therapies. Methods: We used a murine model of IAPA to investigate how influenza predisposes to the development of invasive pulmonary aspergillosis. Immunocompetent mice were challenged with an intranasal instillation of influenza on day 0 followed by an orotracheal inoculation with Aspergillus 4 days later. Mice were monitored daily for overall health status, lung pathology with micro-computed tomography (μCT) and fungal burden with bioluminescence imaging (BLI). At endpoint, high parameter immunophenotyping, spatial transcriptomics, histopathology, dynamic phagosome biogenesis assays with live imaging, immunofluorescence staining, specialized functional phagocytosis and killing assays were performed. Findings: We uncovered an early exuberant influenza-induced interferon-gamma (IFN-γ) production as the major driver of immunopathology in IAPA and delineated the molecular mechanisms. Specifically, excessive IFN-γ production resulted in a defective Th17-immune response, depletion of macrophages, and impaired killing of Aspergillus conidia by macrophages due to the inhibition of NADPH oxidase-dependent activation of LC3-associated phagocytosis (LAP). Markedly, mice with partial or complete genetic ablation of IFN-γ had a restored Th17-immune response, LAP-dependent mechanism of killing and were fully protected from invasive fungal infection. Interpretation: Together, these results identify exuberant viral induced IFN-γ production as a major driver of immune dysfunction in IAPA, paving the way to explore the use of excessive viral-induced IFN-γ as a biomarker and new immunotherapeutic target in IAPA. Funding: This research was funded by the Research Foundation Flanders (FWO), project funding under Grant G053121N to JW, SHB and GVV; G057721N, G0G4820N to GVV; 1506114 N to KL and GVV; KU Leuven internal funds (C24/17/061) to GVV, clinical research funding to JW, Research Foundation Flanders (FWO) aspirant mandate under Grant 1186121N/1186123 N to LS, 11B5520N to FS, 1SF2222N to EV and 11M6922N/11M6924N to SF, travel grants V428023N, K103723N, K217722N to LS. FLvdV was supported by a Vidi grant of the Netherlands Association for Scientific Research. FLvdV, JW, AC and GC were supported by the Europeans Union's Horizon 2020 research and innovation program under grant agreement no 847507 HDM-FUN. AC was also supported by the Fundação para a Ciência e a Tecnologia (FCT), with the references UIDB/50026/2020, UIDP/50026/2020, PTDC/MED-OUT/1112/2021 (https://doi.org/10.54499/PTDC/MED-OUT/1112/2021), and 2022.06674.PTDC (http://doi.org/10.54499/2022.06674.PTDC); and the "la Caixa" Foundation under the agreement LCF/PR/HR22/52420003 (MICROFUN).

An Adenoviral Vector Encoding Full-Length Dectin-1 Promotes Aspergillus -Induced Innate Immune Response in Macrophages

Up-regulation of Dectin-1 in Airway Epithelial Cells Promotes Mice Defense Against Invasive Pulmonary Aspergillosis.

Construction and identification of a recombinant adenoviral vector expressing murine dendritic cell-associ-atedC-type lectin-1

1,25(OH)2D3 and VDR Signaling Pathways Regulate the Inhibition of Dectin-1 Caused by Cyclosporine A in Response to Aspergillus Fumigatus in Human Corneal Epithelial Cells.

Dendritic Cells Transduced with an Adenovirus Vector Encoding Interleukin-12 Are a Potent Vaccine for Invasive Pulmonary Aspergillosis

Dectin-1 Mrna Expression in Lung of Different Immune Status Mice Infected with Aspergillus Fumigatus

Transient Overexpression of Gamma Interferon Promotes Aspergillus Clearance in Invasive Pulmonary Aspergillosis

Dectin-1 is inducible and plays a crucial role in Aspergillus -induced innate immune responses in human bronchial epithelial cells

Influence of Muramyl Dipeptide on the Cytokine Secretion by A549 Cells Stimulated with Aspergillus Fumigatus Conidia and the Possible Mechanisms

The Expression of Dectin-1, Irak1 and Rip2 During the Host Response to Aspergillus fumigatus

Study on identification and security of the murine model administrated with recombi-nant adenovirus encoding murine Dectin-1

Innate and Adaptive Immune Responses Induced by Aspergillus Fumigatus Conidia and Hyphae

Toll-like Receptor 2 and Dectin-1 Function As Promising Biomarker for Aspergillus Fumigatus Infection.

PU.1 Serves a Critical Role in the Innate Defense Against Aspergillus Fumigatus Via Dendritic Cell-Associated C-type Lectin Receptor-1 and Toll-Like Receptors-2 and 4 in THP-1-derived Macrophages

Cyclophosphamide Reduces Dectin-1 Expression in the Lungs of Naive and Aspergillus Fumigatus-Infected Mice

The Construction and Characterization of a Novel Adenovirus Vector of Artificial Microrna Targeting EGFR.

Dectin-1 Facilitates IL-18 Production for the Generation of Protective Antibodies Against Candida albicans

Adoptive Immunity Mediated by HLA-A*0201 Restricted Asp F16 Peptides-Specific CD8+ T Cells Against Aspergillus Fumigatus Infection

Damping excessive viral-induced IFN-γ rescues the impaired anti-Aspergillus host immune response in influenza-associated pulmonary aspergillosis

[Construction and Expression of Recombinant Adenovirus Expression Vector of Beta-Defensin-2].

Activation of NF-κB and Respiratory Burst Following Aspergillus Fumigatus Stimulation of Macrophages